Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

PTC projected adjusted earnings per share of 75 cents to 95 cents for the quarter, compared with analysts' estimate of $1.33. For the fiscal year 2025, PTC expects revenue to be between $2.51 billion ...

Nov 6 (Reuters) - Industrial software maker PTC (PTC.O), opens new tab forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in demand for its industrial design ...

Panellists were announced during annual conference for The Personal Travel Consultants in Partnership with Blue Bay Travel, ...

Key events this week, including the US CPI data and the speech by the Federal Reserve Chair, will be critical in providing ...

ICON plc (NASDAQ:ICLR) traded sharply lower on Thursday, sparking a selloff among its rival contract research organizations after the Ireland-based company cut its guidance with its Q3 results. In ...

A trader wears a hat in support of Republican Donald Trump, after he won the U.S. presidential election, at the New York ...

Brokerage Geojit has set a new target price of Rs 582 owing to surge in large deals which is expected to support the companys ...

It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and ...